Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosei

Showing results (21-30 of 828) with videos related to

Pageof 83
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2012
Synthesis of Ni-Ru alloy nanoparticles and their high catalytic activity in dehydrogenation of ammonia boraneGuozhu Chen, Stefano Desinan, Renzo Rosei, et al.
Blood Pressure|July 24, 2003
Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophyE Agabiti Rosei
Blood Pressure|July 24, 2003
Assessment of preclinical target organ damage in hypertension: carotid intima-media thickness and plaqueE Agabiti Rosei
Blood Pressure. Supplement|January 1, 1997
Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatmentE Agabiti-Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
From macro- to microcirculation: benefits in hypertension and diabetesEnrico Agabiti-Rosei
Hypertension (Dallas, Tex. : 1979)|June 22, 2016
Target Blood Pressure for Treatment: Should Current Recommendations Be Changed?Enrico Agabiti Rosei
Chemical Communications (Cambridge, England)|July 10, 2012
Hollow ruthenium nanoparticles with small dimensions derived from Ni@Ru core@shell structure: synthesis and enhanced catalytic dehydrogenation of ammonia boraneGuozhu Chen, Stefano Desinan, Renzo Rosei, et al.
Nature Materials|January 24, 2013
Photonic crystals: Sustainable sensors from silkJennifer MacLeod, Federico Rosei
Nature Nanotechnology|June 5, 2010
Interfaces: AFM extends its reachAndreas Ruediger, Federico Rosei
Science (New York, N.Y.)|September 10, 2016
Asymmetry in supramolecular assemblySuzette Slim, Federico Rosei
Pageof 83

Showing results (21-30 of 828) with videos related to

Sort By:
Pageof 83
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 28, 2012
Synthesis of Ni-Ru alloy nanoparticles and their high catalytic activity in dehydrogenation of ammonia boraneGuozhu Chen, Stefano Desinan, Renzo Rosei, et al.
Blood Pressure|July 24, 2003
Assessment of preclinical target organ damage in hypertesion: left ventricular hypertrophyE Agabiti Rosei
Blood Pressure|July 24, 2003
Assessment of preclinical target organ damage in hypertension: carotid intima-media thickness and plaqueE Agabiti Rosei
Blood Pressure. Supplement|January 1, 1997
Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatmentE Agabiti-Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 15, 2009
From macro- to microcirculation: benefits in hypertension and diabetesEnrico Agabiti-Rosei
Hypertension (Dallas, Tex. : 1979)|June 22, 2016
Target Blood Pressure for Treatment: Should Current Recommendations Be Changed?Enrico Agabiti Rosei
Chemical Communications (Cambridge, England)|July 10, 2012
Hollow ruthenium nanoparticles with small dimensions derived from Ni@Ru core@shell structure: synthesis and enhanced catalytic dehydrogenation of ammonia boraneGuozhu Chen, Stefano Desinan, Renzo Rosei, et al.
Nature Materials|January 24, 2013
Photonic crystals: Sustainable sensors from silkJennifer MacLeod, Federico Rosei
Nature Nanotechnology|June 5, 2010
Interfaces: AFM extends its reachAndreas Ruediger, Federico Rosei
Science (New York, N.Y.)|September 10, 2016
Asymmetry in supramolecular assemblySuzette Slim, Federico Rosei
Pageof 83